Sign in
4

Changes in Ownership

Cytek Biosciences, Inc. Filed Acc 0001415889-24-004886

CHIEF FINANCIAL OFFICER gave up 683 shares (to pay taxes)

  • CHIEF FINANCIAL OFFICER acquired 1,752 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jeanmonod Patrik CHIEF FINANCIAL OFFICER 2024-02-20 Option exercise +1,752 95,152 D
Jeanmonod Patrik CHIEF FINANCIAL OFFICER 2024-02-20 Shares withheld for taxes −683 $8.38 $5,724 94,469 D
Derivatives
Jeanmonod Patrik CHIEF FINANCIAL OFFICER 2024-02-20 Option exercise · Restricted Stock Units −1,752 13,442 D
Loading xslF345X05/form4-02222024_100242.xml…